Sophie Delhomme Selected Research

fexinidazole

11/2022	Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2-3 trial.
1/2021	Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.
1/2018	Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Delhomme Research Topics

Disease

3	African Trypanosomiasis (Nagana) 01/2023 - 11/2022
2	Malaria 11/2022 - 01/2021
2	Trypanosomiasis 01/2021 - 01/2018
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2023
1	Gonorrhea 01/2023
1	Ocular Onchocerciasis (River Blindness) 10/2021
1	Onchocerciasis 10/2021
1	Helminthiasis (Helminthiases) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Neglected Diseases 01/2018
1	Infections 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

3	fexinidazoleIBA 11/2022 - 01/2018
2	Eflornithine (Ornidyl)FDA Link 01/2023 - 01/2018
2	NifurtimoxIBA 01/2023 - 01/2018
1	Third Generation CephalosporinsIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	BoronIBA 01/2023
1	zoliflodacinIBA 01/2023
1	emodepsideIBA 10/2021
1	imidazoleIBA 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2003
1	poly(lactide) (polylactic acid)IBA 11/2003
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 11/2003
1	Delayed-Action PreparationsIBA 11/2003

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2018
1	Contraindications 01/2021